ANDA 212929, held by Accord Hlthcare. Trientine Hydrochloride.
As of Nov 15, 2026, ANDA 212929 (Trientine Hydrochloride), held by Accord Hlthcare, was first approved by FDA on Aug 30, 2021, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 30, 2021 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Trientine Hydrochloride250MG ยท capsule;oral | Trientine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
